Skip to main content
. 2022 Dec 19;11(24):e026414. doi: 10.1161/JAHA.122.026414

Table 3.

Optical Coherence Tomography Findings

Variables MACE, n=50 No MACE, n=182 P value
Underlying plaque 0.010*
Fibrous plaque 3 (6.0) 40 (22.0)
Lipid plaque 47 (94.0) 142 (78.0)
FCT, μm 100.6±45.7 106.0±49.0 0.775
Mean lipid arc, degree 205.5±42.7 198.5±47.3 0.211
Lipid length, mm 12.3±5.5 13.2±6.4 0.233
Lipid index, mm, degree 2571.2±1267.4 2694.8±1523.7 0.147
Maximum lipid arc, degree 292.3±73.0 283.8±71.9 0.712
TCFA 15 (30.0) 32 (17.6) 0.053*
Macrophage 43 (86.0) 146 (80.2) 0.352
Microchannel 20 (40.0) 77 (42.3) 0.770
Cholesterol crystals 8 (16.0) 44 (24.2) 0.219
Calcification 13 (26.0) 48 (26.4) 0.958
Thrombus type 0.699
Red 7 (14.0) 34 (19.2)
White 29 (58.0) 97(54.8)
Mixed 14 (28.0) 46 (26.0)
Thrombus length, mm 7.1±5.5 7.2±4.9 0.855
Thrombus area, mm2 1.2±1.0 1.0±0.9 0.587
Thrombus volume, mm3 5.6 (2.5–10.2) 4.6 (1.8–10.8) 0.637
Thrombus burden 24.4±10.4 20.4±10.9 0.010*
Thrombus score 54.5 (35.0–85.5) 60.0 (33.0–96.0) 0.747
MLA, mm2 2.3±0.9 2.9±2.0 0.001*
AS% 72.2±9.4 64.2±15.7 <0.001*

Values are expressed as n (%), mean±SD, or median (25th–75th percentiles).

AS% indicates percentage of area stenosis; FCT, fibrous cap thickness; MACE, major adverse cardiovascular events; MLA, minimal lumen area; and TCFA, thin‐cap fibroatheroma.

*

P value<0.05 considered statistically significant.